Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial - Kalinsky, Kevin; Hong, Fangxin; McCourt, Carolyn K; Sachdev, Jasgit C; Mitchell, Edith P; Zwiebel, James A; Doyle, L Austin; McShane, Lisa M; Li, Shuli; Gray, Robert J; Rubinstein, Larry V; Patton, David; et al. (JAMA oncology, 2021)
Keywords: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Breast Neoplasms - pathology; Female; Humans; Middle Aged; National Cancer Institute (U.S.); Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; United States; United States